Open access
Sep 2026
Correction: Efficacy and safety of camrelizumab plus apatinib for solid tumors: a meta-analysis
[This corrects the article DOI: 10.3389/fimmu.2025.1653429.].
Ping Yu, Xiao-Yu Song, Yue Li et al.
· Frontiers in Immunology · 0 citations